s-benzoylmercaptoacetyltriglycine and Ovarian Neoplasms

s-benzoylmercaptoacetyltriglycine has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boven, E; Kievit, E; Pinedo, HM; Schlüper, HM; van Dongen, GA; van Gog, FB	1

Other Studies

1 other study(ies) available for s-benzoylmercaptoacetyltriglycine and Ovarian Neoplasms

Article	Year
[186Re]-labeled mouse and chimeric monoclonal antibody 323/A3: a comparison of the efficacy in experimental human ovarian cancer. Nuclear medicine and biology, 1998, Volume: 25, Issue:1 Topics: Animals; Antibodies, Monoclonal; Chelating Agents; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Glycine; Humans; Immunotoxins; Isoelectric Point; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Radioimmunotherapy; Radioisotopes; Recombinant Fusion Proteins; Rhenium; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured	1998

Article

Year

[186Re]-labeled mouse and chimeric monoclonal antibody 323/A3: a comparison of the efficacy in experimental human ovarian cancer.

Nuclear medicine and biology, 1998, Volume: 25, Issue:1

Topics: Animals; Antibodies, Monoclonal; Chelating Agents; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Glycine; Humans; Immunotoxins; Isoelectric Point; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Radioimmunotherapy; Radioisotopes; Recombinant Fusion Proteins; Rhenium; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured

1998